2022 BOX TRIAL: BP TARGETS IN OHCA Blood-pressure targets in comatose survivors of cardiac arrest Investigator-initiated, double-blind, superiority, 2×2 factorial design, randomized clinical trial Objective: To evaluate the appropriate blood pressure target in comatose survivors of out-of-hospital cardiac arrest 789 … Read More
Cardiovascular Disease
ADVOR Trial Summary: Acetazolamide in Acute Decompensated Heart Failure with Volume Overload
2022 ADVOR STUDY Acetazolamide in acute decompensated heart failure with volume overload multicenter, parallel-group, double-blind, randomized, placebo-controlled trial a d Objective: To compare the incidence of successful decongestion with addition of acetazolamide vs placebo to loop diuretic therapy in patients … Read More
METEORIC-HF Trial Summary: Omecamtiv Mecarbil Effect of Exerciser in HFrEF
2022 METEORIC-HF Effect of Omecamtiv mecarbil on exercise capacity in chronic heart failure with reduced ejection fraction Phase 3, double-blind, placebo-controlled randomized trial a Objective: To determine whether omecamtiv mecarbil, a novel direct myosin activator improves peak exercise capacity in … Read More
INVICTUS Trial Summary: Rivaroxaban in Rheumatic Heart Disease–Associated AFib
2022 INVICTUS TRIAL Rivaroxaban in rheumatic heart disease associated atrial fibrillation (AF) Prospective, parallel group, open-label, randomized clinical trial d e Objective: To evaluate Rivaroxaban compared with Vitamin K antagonist among patients with rheumatic heart disease & atrial fibrillation antagonis … Read More
SODIUM-HF Trial Summary: Reduction of dietary sodium in Heart Failure
2022 SODIUM-HF TRIAL Reduction of dietary sodium to less than 100 mmol in heart failure International, open-label, randomised, controlled trial Objective: To evaluate if a low-sodium diet (<1500 mg daily) compared to usual care in ambulatory patients with heart failure … Read More
SECURE Trial Summary: Polypill Strategy in Secondary Cardiovascular Prevention
2022 SECURE TRIAL Polypill Strategy in Secondary Cardiovascular Prevention Phase 3, randomized, controlled clinical trial Objective: To evaluate the effect of polypill that includes key medications (aspirin, ramipril, and atorvastatin) on cardiovascular events in post-Ml patients. 2499 Inclusion criteria: Patients … Read More
ARREST Trial: ECMO-facilitated Resuscitation in Refractory Cardiac Arrest
2020 ARREST 2020 TRIAL M Advanced reperfusion strategies for patients with out-of hospital cardiac arrest (OHCA) and refractory ventricular fibrillation (VF) Phase 2, single center, open-label, randomized clinical trial Objective: To compare implementation of early ECMO facilitated resuscitation compared to … Read More
EMPULSE Trial Summary: Empagliflozin in Acute Heart Failure
2021 EMPULSE TRIAL Empagliflozin in patients hospitalized for Acute Heart Failure Randomized, parallel trial Objective: To evaluate empagliflozin compared with placebo among patients with acute decompensated heart failure. 530 patients Inclusion criteria: Patients hospitalized for acute HF regardless of ejection … Read More
AVATAR Trial Summary: AVR in Asymptomatic Severe Aortic Stenosis
2021 AVATAR TRIAL M Aortic Valve replacement versus Conservative treatment in asymptomatic severe Aortic Stenosis Parallel, Randomised controlled trial Objective: To evaluate aortic valve replacement (AVR) compared with conservative therapy among patients with asymptomatic severe aortic stenosis 157 Inclusion criteria: … Read More
PALACS Trial Summary: Posterior Left Pericardiotomy for Post-op AFib
2021 PALACS TRIAL M Posterior left pericardiotomy for the prevention of postoperative atrial fibrillation after cardiac surgery Randomized, parallel, stratified, single-centre study Objective: To evaluate posterior left pericardiotomy compared with no intervention among patients undergoing open heart surgery 420 patients … Read More